banner
Home / News / Two studies spotlight intestinal T cells that could be targeted to prevent resistance to ICB cancer therapy
News

Two studies spotlight intestinal T cells that could be targeted to prevent resistance to ICB cancer therapy

Dec 28, 2023Dec 28, 2023

Dr. Cameron McAlpine

To commemorate World Multiple Sclerosis (MS) Day, we speak to Dr. Cameron McAlpine about his latest research that sought to understand better the proteins and signals that act as messengers between brain and immune cells in MS.